Alerts will be sent to your verified email
Verify EmailVINEETLAB
|
Vineet Laboratories
|
Deccan Health Care
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-20.75 % | 0.79 % | 3.78 % |
|
5yr average Equity Multiplier
|
4.27 | 1.17 | 3.3 |
|
5yr Average Asset Turnover Ratio
|
1.52 | 0.47 | 0.77 |
|
5yr Avg Net Profit Margin
|
-4.28 % | 1.37 % | -2.26 % |
|
Price to Book
|
2.81 | 0.37 | 0.61 |
|
P/E
|
0.0 | 37.83 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
179.8 Days | 218.27 Days | 70.26 Days |
|
Inventory Days
|
114.74 Days | 372.92 Days | 107.37 Days |
|
Days Receivable
|
109.14 Days | 54.52 Days | 274.82 Days |
|
Days Payable
|
115.29 Days | 94.94 Days | 235.98 Days |
|
5yr Average Interest Coverage Ratio
|
1.29 | 12.96 | 1.81 |
|
5yr Avg ROCE
|
-1.66 % | 2.08 % | 15.08 % |
|
5yr Avg Operating Profit Margin
|
-0.62 % | 7.39 % | 7.68 % |
|
5 yr average Debt to Equity
|
1.24 | 0.02 | 0.97 |
|
5yr CAGR Net Profit
|
n/a | 24.36 % | n/a |
|
5yr Average Return on Assets
|
-2.52 % | 0.68 % | 1.04 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
15.89 % | 18.42 % | 70.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 44.88 % |
|
Change in Promoter Holding (3 Yrs)
|
-20.07 % | -9.18 % | -0.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vineet Laboratories
|
Deccan Health Care
|
ANG Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|